SCHEMBL6327431

SCHEMBL6327431

CCCCCC=C1CCC(=CC(C)C)C1=O

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
KDM4E B2RXH2 2/20 0.42
MEN1 O00255 2/20 0.41
MAPT P10636 2/20 0.41
KMT2A Q03164 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41
MCOLN3 Q8TDD5 1/20 0.41
ALDH1A1 P00352 1/20 0.39
PRKCA P17252 13/20 0.37
CCR6 P51684 1/20 0.37
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
FAAH O00519 1/20 0.34
MGLL Q99685 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6326522 0.95 RAB9A (0.46) RAB9AL3MBTL1KDM4EMEN1MAPT
SCHEMBL6325301 0.87 RAB9A (0.44) RAB9AL3MBTL1KDM4EMEN1MAPT
SCHEMBL6330898 0.87 KDM4E (0.49) RAB9AL3MBTL1KDM4EPRKCACCR6
SCHEMBL6330897 0.87 KDM4E (0.49) RAB9AL3MBTL1KDM4EPRKCACCR6
SCHEMBL6328042 0.85 KDM4E (0.51) RAB9AL3MBTL1KDM4EPRKCACCR6
SCHEMBL6328046 0.85 KDM4E (0.51) RAB9AL3MBTL1KDM4EPRKCACCR6
SCHEMBL6331100 0.83 KDM4E (0.47) RAB9AL3MBTL1KDM4EPRKCACCR6
SCHEMBL6325721 0.83 KDM4E (0.50) RAB9AL3MBTL1KDM4EPRKCACCR6
SCHEMBL6331101 0.83 KDM4E (0.47) RAB9AL3MBTL1KDM4EPRKCACCR6
SCHEMBL6325723 0.83 KDM4E (0.50) RAB9AL3MBTL1KDM4EPRKCACCR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009928-A1 Cyclopentanone derivative ZEON CORPORATION (JP) 2005-01-13 US disclosed
EP-1420005-A1 CYCLOPENTANONE DERIVATIVE Zeon Corporation (JP) 2004-05-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009928-A1 Cyclopentanone derivative PTGIS, CYP51A1, TRPA1 RAB9A 4009/4885L3MBTL1 4713/4885KDM4E 2486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.